Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences

Abstract Objective To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Background Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain & development (Tokyo. 1979) 2017-05, Vol.39 (5), p.386-394
Hauptverfasser: Saito, Yoshiaki, Yamanaka, Gaku, Shimomura, Hideki, Shiraishi, Kazuhiro, Nakazawa, Tomoyuki, Kato, Fumihide, Shimizu-Motohashi, Yuko, Sasaki, Masayuki, Maegaki, Yoshihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 394
container_issue 5
container_start_page 386
container_title Brain & development (Tokyo. 1979)
container_volume 39
creator Saito, Yoshiaki
Yamanaka, Gaku
Shimomura, Hideki
Shiraishi, Kazuhiro
Nakazawa, Tomoyuki
Kato, Fumihide
Shimizu-Motohashi, Yuko
Sasaki, Masayuki
Maegaki, Yoshihiro
description Abstract Objective To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Background Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine without aura, there have been no studies regarding the efficacy of these drugs in childhood migraine without aura not filling the diagnostic criteria. Methods In total, 154 patients with a clinical diagnosis of migraine, with onset of repetitive headaches at the age of ⩽15 years, were retrospectively included from clinics in seven tertiary medical centers. Results Patients’ diagnoses included migraine with aura ( n = 49), migraine without aura ( n = 65), clinical migraine without aura not fulfilling International Classification of Headache Disorders-3 beta criteria (suspected migraine without aura; n = 38), and hemiplegic migraine ( n = 2). Abortive medicine was effective in 74 of 97 patients, and preventive medicine was effective in 61 of 84 patients. Drugs with high efficacy were acetaminophen and ibuprofen for abortive therapy and cyproheptadine, amitriptyline, and propranolol for preventive therapy. Psychosocial problems were less common, and abnormalities on electroencephalography were more common in the suspected migraine without aura group. Otherwise, clinical features and drug responsibility were comparable among the migraine with aura, migraine without aura, and suspected migraine without aura groups. Retrospectively, experts clinically diagnosed childhood migraine without aura when the headache met at least one of the three criteria B, C, and D in International Classification of Headache Disorders-3 beta in addition to A and E. Abortive and preventive medication including paroxetine ( n = 2) benefited 10 and 15 of the 33 patients with daily headache, respectively. Psychotherapy/counseling ( n = 4), treatment for orthostatic dysregulation ( n = 4), and elimination of stressors ( n = 3) markedly alleviated headache in this group. Conclusion Our results indicated that those with suspected migraine without aura not filling International Classification of Headache Disorders diagnostic criteria should be included in the treatment for migraine. Treatment should also be targeted to comorbid developmental disorders, orthostatic dysregulation, and psychosocial problems in patients with refractory daily headaches.
doi_str_mv 10.1016/j.braindev.2016.11.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1851298298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0387760416301966</els_id><sourcerecordid>1851298298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-68cbeefbef07ac4631a073811bb641ba216ec5efa55adbd5b1f25a2ad78876913</originalsourceid><addsrcrecordid>eNqFkUtv1DAQgC0EokvhL1Q5cknqsTd2wgFRVVCQKlXicbb8mHS9JHaws4X--ya7XQ69VLJkefzNjP0NIWdAK6AgzreVSdoHh3cVm88VQEUBXpAVNJKVEji8JCvKG1lKQdcn5E3OW0opMKCvyQmTbcvXTK7I-B1tDNk7THryMRSxK6YNFs7r2xCzz4UOrpgS6mnAMC3XduN7t4nRFYO_XR6BH4qLYkzaTt7qvkh45_Hvnux92Ifw34jJY7CY35JXne4zvnvcT8mvL59_Xn4tr2-uvl1eXJe25u1UisYaxM5gR6W2a8FBU8kbAGPEGoxmINDW2Om61s642kDHas20k00jRQv8lLw_1B1T_LPDPKnBZ4t9rwPGXVbQ1MDaZl4zKg6oTTHnhJ0akx90uldA1WJbbdXRtlpsKwA1254Tzx577MyA7n_aUe8MfDoAOP90tpJUtnsNzie0k3LRP9_j45MSR6u_8R7zNu5SmD0qUJkpqn4sM19GDoJTaIXgD-jgq10</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1851298298</pqid></control><display><type>article</type><title>Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Saito, Yoshiaki ; Yamanaka, Gaku ; Shimomura, Hideki ; Shiraishi, Kazuhiro ; Nakazawa, Tomoyuki ; Kato, Fumihide ; Shimizu-Motohashi, Yuko ; Sasaki, Masayuki ; Maegaki, Yoshihiro</creator><creatorcontrib>Saito, Yoshiaki ; Yamanaka, Gaku ; Shimomura, Hideki ; Shiraishi, Kazuhiro ; Nakazawa, Tomoyuki ; Kato, Fumihide ; Shimizu-Motohashi, Yuko ; Sasaki, Masayuki ; Maegaki, Yoshihiro</creatorcontrib><description>Abstract Objective To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Background Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine without aura, there have been no studies regarding the efficacy of these drugs in childhood migraine without aura not filling the diagnostic criteria. Methods In total, 154 patients with a clinical diagnosis of migraine, with onset of repetitive headaches at the age of ⩽15 years, were retrospectively included from clinics in seven tertiary medical centers. Results Patients’ diagnoses included migraine with aura ( n = 49), migraine without aura ( n = 65), clinical migraine without aura not fulfilling International Classification of Headache Disorders-3 beta criteria (suspected migraine without aura; n = 38), and hemiplegic migraine ( n = 2). Abortive medicine was effective in 74 of 97 patients, and preventive medicine was effective in 61 of 84 patients. Drugs with high efficacy were acetaminophen and ibuprofen for abortive therapy and cyproheptadine, amitriptyline, and propranolol for preventive therapy. Psychosocial problems were less common, and abnormalities on electroencephalography were more common in the suspected migraine without aura group. Otherwise, clinical features and drug responsibility were comparable among the migraine with aura, migraine without aura, and suspected migraine without aura groups. Retrospectively, experts clinically diagnosed childhood migraine without aura when the headache met at least one of the three criteria B, C, and D in International Classification of Headache Disorders-3 beta in addition to A and E. Abortive and preventive medication including paroxetine ( n = 2) benefited 10 and 15 of the 33 patients with daily headache, respectively. Psychotherapy/counseling ( n = 4), treatment for orthostatic dysregulation ( n = 4), and elimination of stressors ( n = 3) markedly alleviated headache in this group. Conclusion Our results indicated that those with suspected migraine without aura not filling International Classification of Headache Disorders diagnostic criteria should be included in the treatment for migraine. Treatment should also be targeted to comorbid developmental disorders, orthostatic dysregulation, and psychosocial problems in patients with refractory daily headaches.</description><identifier>ISSN: 0387-7604</identifier><identifier>EISSN: 1872-7131</identifier><identifier>DOI: 10.1016/j.braindev.2016.11.011</identifier><identifier>PMID: 27993427</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Analgesics, Non-Narcotic - therapeutic use ; Autism spectrum disorders ; Child ; Childhood ; Developmental Disabilities - drug therapy ; Developmental Disabilities - etiology ; Electroencephalography ; Headache - drug therapy ; Headache - epidemiology ; Humans ; Migraine ; Migraine Disorders - complications ; Migraine Disorders - diagnosis ; Migraine Disorders - epidemiology ; Migraine Disorders - therapy ; Neurology ; Orthostatic dysregulation ; Pervasive developmental disorder ; Retrospective Studies</subject><ispartof>Brain &amp; development (Tokyo. 1979), 2017-05, Vol.39 (5), p.386-394</ispartof><rights>The Japanese Society of Child Neurology</rights><rights>2016 The Japanese Society of Child Neurology</rights><rights>Copyright © 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-68cbeefbef07ac4631a073811bb641ba216ec5efa55adbd5b1f25a2ad78876913</citedby><cites>FETCH-LOGICAL-c539t-68cbeefbef07ac4631a073811bb641ba216ec5efa55adbd5b1f25a2ad78876913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.braindev.2016.11.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27993427$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saito, Yoshiaki</creatorcontrib><creatorcontrib>Yamanaka, Gaku</creatorcontrib><creatorcontrib>Shimomura, Hideki</creatorcontrib><creatorcontrib>Shiraishi, Kazuhiro</creatorcontrib><creatorcontrib>Nakazawa, Tomoyuki</creatorcontrib><creatorcontrib>Kato, Fumihide</creatorcontrib><creatorcontrib>Shimizu-Motohashi, Yuko</creatorcontrib><creatorcontrib>Sasaki, Masayuki</creatorcontrib><creatorcontrib>Maegaki, Yoshihiro</creatorcontrib><title>Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences</title><title>Brain &amp; development (Tokyo. 1979)</title><addtitle>Brain Dev</addtitle><description>Abstract Objective To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Background Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine without aura, there have been no studies regarding the efficacy of these drugs in childhood migraine without aura not filling the diagnostic criteria. Methods In total, 154 patients with a clinical diagnosis of migraine, with onset of repetitive headaches at the age of ⩽15 years, were retrospectively included from clinics in seven tertiary medical centers. Results Patients’ diagnoses included migraine with aura ( n = 49), migraine without aura ( n = 65), clinical migraine without aura not fulfilling International Classification of Headache Disorders-3 beta criteria (suspected migraine without aura; n = 38), and hemiplegic migraine ( n = 2). Abortive medicine was effective in 74 of 97 patients, and preventive medicine was effective in 61 of 84 patients. Drugs with high efficacy were acetaminophen and ibuprofen for abortive therapy and cyproheptadine, amitriptyline, and propranolol for preventive therapy. Psychosocial problems were less common, and abnormalities on electroencephalography were more common in the suspected migraine without aura group. Otherwise, clinical features and drug responsibility were comparable among the migraine with aura, migraine without aura, and suspected migraine without aura groups. Retrospectively, experts clinically diagnosed childhood migraine without aura when the headache met at least one of the three criteria B, C, and D in International Classification of Headache Disorders-3 beta in addition to A and E. Abortive and preventive medication including paroxetine ( n = 2) benefited 10 and 15 of the 33 patients with daily headache, respectively. Psychotherapy/counseling ( n = 4), treatment for orthostatic dysregulation ( n = 4), and elimination of stressors ( n = 3) markedly alleviated headache in this group. Conclusion Our results indicated that those with suspected migraine without aura not filling International Classification of Headache Disorders diagnostic criteria should be included in the treatment for migraine. Treatment should also be targeted to comorbid developmental disorders, orthostatic dysregulation, and psychosocial problems in patients with refractory daily headaches.</description><subject>Adolescent</subject><subject>Analgesics, Non-Narcotic - therapeutic use</subject><subject>Autism spectrum disorders</subject><subject>Child</subject><subject>Childhood</subject><subject>Developmental Disabilities - drug therapy</subject><subject>Developmental Disabilities - etiology</subject><subject>Electroencephalography</subject><subject>Headache - drug therapy</subject><subject>Headache - epidemiology</subject><subject>Humans</subject><subject>Migraine</subject><subject>Migraine Disorders - complications</subject><subject>Migraine Disorders - diagnosis</subject><subject>Migraine Disorders - epidemiology</subject><subject>Migraine Disorders - therapy</subject><subject>Neurology</subject><subject>Orthostatic dysregulation</subject><subject>Pervasive developmental disorder</subject><subject>Retrospective Studies</subject><issn>0387-7604</issn><issn>1872-7131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAQgC0EokvhL1Q5cknqsTd2wgFRVVCQKlXicbb8mHS9JHaws4X--ya7XQ69VLJkefzNjP0NIWdAK6AgzreVSdoHh3cVm88VQEUBXpAVNJKVEji8JCvKG1lKQdcn5E3OW0opMKCvyQmTbcvXTK7I-B1tDNk7THryMRSxK6YNFs7r2xCzz4UOrpgS6mnAMC3XduN7t4nRFYO_XR6BH4qLYkzaTt7qvkh45_Hvnux92Ifw34jJY7CY35JXne4zvnvcT8mvL59_Xn4tr2-uvl1eXJe25u1UisYaxM5gR6W2a8FBU8kbAGPEGoxmINDW2Om61s642kDHas20k00jRQv8lLw_1B1T_LPDPKnBZ4t9rwPGXVbQ1MDaZl4zKg6oTTHnhJ0akx90uldA1WJbbdXRtlpsKwA1254Tzx577MyA7n_aUe8MfDoAOP90tpJUtnsNzie0k3LRP9_j45MSR6u_8R7zNu5SmD0qUJkpqn4sM19GDoJTaIXgD-jgq10</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Saito, Yoshiaki</creator><creator>Yamanaka, Gaku</creator><creator>Shimomura, Hideki</creator><creator>Shiraishi, Kazuhiro</creator><creator>Nakazawa, Tomoyuki</creator><creator>Kato, Fumihide</creator><creator>Shimizu-Motohashi, Yuko</creator><creator>Sasaki, Masayuki</creator><creator>Maegaki, Yoshihiro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences</title><author>Saito, Yoshiaki ; Yamanaka, Gaku ; Shimomura, Hideki ; Shiraishi, Kazuhiro ; Nakazawa, Tomoyuki ; Kato, Fumihide ; Shimizu-Motohashi, Yuko ; Sasaki, Masayuki ; Maegaki, Yoshihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-68cbeefbef07ac4631a073811bb641ba216ec5efa55adbd5b1f25a2ad78876913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Analgesics, Non-Narcotic - therapeutic use</topic><topic>Autism spectrum disorders</topic><topic>Child</topic><topic>Childhood</topic><topic>Developmental Disabilities - drug therapy</topic><topic>Developmental Disabilities - etiology</topic><topic>Electroencephalography</topic><topic>Headache - drug therapy</topic><topic>Headache - epidemiology</topic><topic>Humans</topic><topic>Migraine</topic><topic>Migraine Disorders - complications</topic><topic>Migraine Disorders - diagnosis</topic><topic>Migraine Disorders - epidemiology</topic><topic>Migraine Disorders - therapy</topic><topic>Neurology</topic><topic>Orthostatic dysregulation</topic><topic>Pervasive developmental disorder</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saito, Yoshiaki</creatorcontrib><creatorcontrib>Yamanaka, Gaku</creatorcontrib><creatorcontrib>Shimomura, Hideki</creatorcontrib><creatorcontrib>Shiraishi, Kazuhiro</creatorcontrib><creatorcontrib>Nakazawa, Tomoyuki</creatorcontrib><creatorcontrib>Kato, Fumihide</creatorcontrib><creatorcontrib>Shimizu-Motohashi, Yuko</creatorcontrib><creatorcontrib>Sasaki, Masayuki</creatorcontrib><creatorcontrib>Maegaki, Yoshihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Brain &amp; development (Tokyo. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saito, Yoshiaki</au><au>Yamanaka, Gaku</au><au>Shimomura, Hideki</au><au>Shiraishi, Kazuhiro</au><au>Nakazawa, Tomoyuki</au><au>Kato, Fumihide</au><au>Shimizu-Motohashi, Yuko</au><au>Sasaki, Masayuki</au><au>Maegaki, Yoshihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences</atitle><jtitle>Brain &amp; development (Tokyo. 1979)</jtitle><addtitle>Brain Dev</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>39</volume><issue>5</issue><spage>386</spage><epage>394</epage><pages>386-394</pages><issn>0387-7604</issn><eissn>1872-7131</eissn><abstract>Abstract Objective To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Background Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine without aura, there have been no studies regarding the efficacy of these drugs in childhood migraine without aura not filling the diagnostic criteria. Methods In total, 154 patients with a clinical diagnosis of migraine, with onset of repetitive headaches at the age of ⩽15 years, were retrospectively included from clinics in seven tertiary medical centers. Results Patients’ diagnoses included migraine with aura ( n = 49), migraine without aura ( n = 65), clinical migraine without aura not fulfilling International Classification of Headache Disorders-3 beta criteria (suspected migraine without aura; n = 38), and hemiplegic migraine ( n = 2). Abortive medicine was effective in 74 of 97 patients, and preventive medicine was effective in 61 of 84 patients. Drugs with high efficacy were acetaminophen and ibuprofen for abortive therapy and cyproheptadine, amitriptyline, and propranolol for preventive therapy. Psychosocial problems were less common, and abnormalities on electroencephalography were more common in the suspected migraine without aura group. Otherwise, clinical features and drug responsibility were comparable among the migraine with aura, migraine without aura, and suspected migraine without aura groups. Retrospectively, experts clinically diagnosed childhood migraine without aura when the headache met at least one of the three criteria B, C, and D in International Classification of Headache Disorders-3 beta in addition to A and E. Abortive and preventive medication including paroxetine ( n = 2) benefited 10 and 15 of the 33 patients with daily headache, respectively. Psychotherapy/counseling ( n = 4), treatment for orthostatic dysregulation ( n = 4), and elimination of stressors ( n = 3) markedly alleviated headache in this group. Conclusion Our results indicated that those with suspected migraine without aura not filling International Classification of Headache Disorders diagnostic criteria should be included in the treatment for migraine. Treatment should also be targeted to comorbid developmental disorders, orthostatic dysregulation, and psychosocial problems in patients with refractory daily headaches.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27993427</pmid><doi>10.1016/j.braindev.2016.11.011</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0387-7604
ispartof Brain & development (Tokyo. 1979), 2017-05, Vol.39 (5), p.386-394
issn 0387-7604
1872-7131
language eng
recordid cdi_proquest_miscellaneous_1851298298
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adolescent
Analgesics, Non-Narcotic - therapeutic use
Autism spectrum disorders
Child
Childhood
Developmental Disabilities - drug therapy
Developmental Disabilities - etiology
Electroencephalography
Headache - drug therapy
Headache - epidemiology
Humans
Migraine
Migraine Disorders - complications
Migraine Disorders - diagnosis
Migraine Disorders - epidemiology
Migraine Disorders - therapy
Neurology
Orthostatic dysregulation
Pervasive developmental disorder
Retrospective Studies
title Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A31%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reconsideration%20of%20the%20diagnosis%20and%20treatment%20of%20childhood%20migraine:%20A%20practical%20review%20of%20clinical%20experiences&rft.jtitle=Brain%20&%20development%20(Tokyo.%201979)&rft.au=Saito,%20Yoshiaki&rft.date=2017-05-01&rft.volume=39&rft.issue=5&rft.spage=386&rft.epage=394&rft.pages=386-394&rft.issn=0387-7604&rft.eissn=1872-7131&rft_id=info:doi/10.1016/j.braindev.2016.11.011&rft_dat=%3Cproquest_cross%3E1851298298%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1851298298&rft_id=info:pmid/27993427&rft_els_id=1_s2_0_S0387760416301966&rfr_iscdi=true